Acquisition by Wendy McDermott of 156950 shares of Lexicon Pharmaceuticals subject to Rule 16b-3
LXRX Stock | USD 1.92 0.05 2.67% |
Slightly above 70 percent of all Lexicon Pharmaceuticals' investors are curious in acquiring. The analysis of the overall investor sentiment regarding Lexicon Pharmaceuticals suggests that a large number of traders are confidant. Lexicon Pharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Lexicon Pharmaceuticals. The current market sentiment, together with Lexicon Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Lexicon Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Lexicon Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Lexicon daily returns and investor perception about the current price of Lexicon Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Lexicon |
Filed transaction by Lexicon Pharmaceuticals Officer Vp, Human Resources. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Lexicon Pharmaceuticals' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Lexicon Pharmaceuticals' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Lexicon Pharmaceuticals Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Lexicon Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Lexicon Pharmaceuticals Fundamental Analysis
We analyze Lexicon Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lexicon Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lexicon Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
Lexicon Pharmaceuticals is currently under evaluation in return on asset category among related companies. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Lexicon Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lexicon Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Lexicon Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Lexicon Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Lexicon Pharmaceuticals Related Equities
HEPA | Hepion Pharmaceuticals | 6.61 | ||||
HOOK | Hookipa Pharma | 6.49 | ||||
GRTX | Galera Therapeutics | 5.88 | ||||
DAWN | Day One | 3.55 | ||||
BLRX | BioLineRx | 3.23 | ||||
OCEA | Ocean Biomedical | 2.63 | ||||
TERN | Terns Pharmaceuticals | 1.70 | ||||
XFOR | X4 Pharmaceuticals | 1.02 | ||||
ELEV | Elevation Oncology | 0.56 | ||||
MREO | Mereo BioPharma | 0.34 | ||||
EFTR | Effector Therapeutics | 1.48 | ||||
ENVB | Enveric Biosciences | 2.38 | ||||
IBRX | Immunitybio | 2.67 | ||||
ARDX | Ardelyx | 2.87 | ||||
AVRO | AVROBIO | 4.44 | ||||
MCRB | Seres Therapeutics | 7.22 |
Check out Lexicon Pharmaceuticals Hype Analysis, Lexicon Pharmaceuticals Correlation and Lexicon Pharmaceuticals Performance. For more information on how to buy Lexicon Stock please use our How to Invest in Lexicon Pharmaceuticals guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for Lexicon Stock analysis
When running Lexicon Pharmaceuticals' price analysis, check to measure Lexicon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexicon Pharmaceuticals is operating at the current time. Most of Lexicon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lexicon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexicon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lexicon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is Lexicon Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lexicon Pharmaceuticals. If investors know Lexicon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lexicon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.63) | Earnings Share (0.83) | Revenue Per Share 0.01 | Quarterly Revenue Growth 46.083 | Return On Assets (0.40) |
The market value of Lexicon Pharmaceuticals is measured differently than its book value, which is the value of Lexicon that is recorded on the company's balance sheet. Investors also form their own opinion of Lexicon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Lexicon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lexicon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Lexicon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lexicon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lexicon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lexicon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.